Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

631 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".
Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS. Polman CH, et al. Ann Neurol. 2005 Dec;58(6):840-6. doi: 10.1002/ana.20703. Ann Neurol. 2005. PMID: 16283615 Review.
Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.
Kappos L, Moeri D, Radue EW, Schoetzau A, Schweikert K, Barkhof F, Miller D, Guttmann CR, Weiner HL, Gasperini C, Filippi M. Kappos L, et al. Lancet. 1999 Mar 20;353(9157):964-9. doi: 10.1016/s0140-6736(98)03053-0. Lancet. 1999. PMID: 10459905
Use of composite scores in the quantification of deterioration in multiple sclerosis.
Lienert C, Lechner-Scott J, Schött D, Constantinescu C, Kappos L. Lienert C, et al. Mult Scler. 1999 Aug;5(4):220-2. doi: 10.1177/135245859900500405. Mult Scler. 1999. PMID: 10467379 Review. No abstract available.
Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group.
Kappos L, Comi G, Panitch H, Oger J, Antel J, Conlon P, Steinman L. Kappos L, et al. Nat Med. 2000 Oct;6(10):1176-82. doi: 10.1038/80525. Nat Med. 2000. PMID: 11017151 Clinical Trial.
The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis.
Lindberg RL, De Groot CJ, Montagne L, Freitag P, van der Valk P, Kappos L, Leppert D. Lindberg RL, et al. Brain. 2001 Sep;124(Pt 9):1743-53. doi: 10.1093/brain/124.9.1743. Brain. 2001. PMID: 11522577
Visual and motor evoked potentials in the course of multiple sclerosis.
Fuhr P, Borggrefe-Chappuis A, Schindler C, Kappos L. Fuhr P, et al. Brain. 2001 Nov;124(Pt 11):2162-8. doi: 10.1093/brain/124.11.2162. Brain. 2001. PMID: 11673318 Clinical Trial.
Evoked potentials for evaluation of multiple sclerosis.
Fuhr P, Kappos L. Fuhr P, et al. Clin Neurophysiol. 2001 Dec;112(12):2185-9. doi: 10.1016/s1388-2457(01)00687-3. Clin Neurophysiol. 2001. PMID: 11738188 Review.
631 results
Jump to page
Feedback